SINGAPORE – A calm finish by unlikely hero, Lionel Tan, lit up an otherwise drab encounter as the Lion City Sailors beat title rivals BG Tampines Rovers 1-0 in the Singapore Premier League (SPL ...

The market was pleased with the recent earnings report from GSK plc (LON:GSK), despite the profit numbers being soft. However, we think the company is showing some signs that things are more ...

GSK's revenue and EPS exceeded my expectations and those of analysts, thanks to the strong performance of its oncology and HIV franchises. So, Ojjaara/Omjjara sales amounted to $150 million in the ...

LONDON, - British drugmaker GSK will no longer set diversity targets, it said on Thursday, as it became the latest company to scale back or abandon such goals in response to the U.S. president's ...

After calling Rockville, Maryland, home for more than eight years, GSK's vaccine and infectious disease R&D teams are planning a move northeast to Cambridge, Massachusetts, the company confirmed ...

GSK’s majority-owned HIV unit ViiV has agreed licensing deals with a trio of generic manufacturers to make its recently-approved long-acting drug for pre-exposure prophylaxis (PrEP) available in ...

Houston Dynamo fans planning to attend Sunday's game against Inter Miami won't see their team face Argentinian star Lionel Messi. Because of his unavailability, they'll receive complimentary ...

After Lionel Messi didn’t make the trip to Houston, the Dynamo offered fans who purchased tickets for Sunday’s game against Inter Miami a make-up for their troubles. Matches against Messi ...

Now, GSK is ready to play catch-up after nabbing its own FDA approval. The FDA approved the British drugmaker's Penmenvy vaccine to protect people ages 10 to 25 against meningococcal serogroups A ...

GSK has fired a shot across the bows of Gilead Sciences' HIV juggernaut Biktarvy, with new data showing its rival therapy Dovato is as effective but causes less weight gain. The results of the ...

GSK's sales rose by 7 per cent to £31.7billion last year, thanks to increasing demand for HIV treatments and oncology medicines, as well as purchases of its meningitis vaccines by the CDC.

CDC vaccine advisors are set to discuss recommendations for the vaccine on Feb. 26. The FDA approved GSK’s pentavalent meningococcal vaccine to protect children and young adults aged 10 to 25 ...